{"id":"W2743322456","doi":"10.1182/blood.v128.22.3045.3045","title":"Ribavirin, an eIF4E Inhibitor, As a Potential Anti-Lymphoma Therapeutic - Preclinical and Early Clinical Data","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Respiratory viral infections research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Ribavirin; EIF4E; Cancer research; Biology; Lymphoma; Virology; Immunology; Virus; Translation (biology); Pharmacology; Messenger RNA; Gene; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001036394,0.0006217207,0.0007318998,0.0004073282,0.0002119607,0.001162839,0.0004924428,0.0006171344,0.006167691],"category_scores_gemma":[0.0006343893,0.0001699586,0.0006344939,0.0003893833,0.0003377026,0.0005487041,0.0002436966,0.002796801,0.001982021],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004758622,"about_ca_system_score_gemma":0.0005950193,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000305579,"about_ca_topic_score_gemma":0.0008642611,"domain_scores_codex":[0.999738,0.00007994387,0.00002284706,0.00003211472,0.00007918932,0.00004783068],"domain_scores_gemma":[0.9995346,0.00010161,0.0000720641,0.00004537205,0.0001157089,0.0001306289],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01855404,0.0110051,0.003474208,0.005223308,0.0005086319,0.0006586249,0.0002095763,0.002334411,0.3493237,0.002478492,0.02857702,0.5776528],"study_design_scores_gemma":[0.009979579,0.1207364,0.02450627,0.001812998,0.001339347,0.004191502,0.0002499957,0.00331516,0.3420296,0.002532956,0.4891897,0.0001163962],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4974547,0.400493,0.01133405,0.009309248,0.001826377,0.002274302,0.01154941,0.001036335,0.06472262],"genre_scores_gemma":[0.7939618,0.1553088,0.008211561,0.006114165,0.0005154784,0.0009167339,0.01543412,0.0001933671,0.019344],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006167691,"threshold_uncertainty_score":0.02063292,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1557574211982435,"score_gpt":0.4546408637951017,"score_spread":0.2988834425968581,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}